People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pulse Therapeutics, Inc. | — | Biotechnology | Series A | $12.7M | $203.0M | 2011 |
Amy L. Boyet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amy L. Boyet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Morris | 1 | 7 |
| ERIC MOESSINGER | 1 | 6 |
| Bevil J Hogg | 1 | 5 |
| THOMAS HILLMAN | 1 | 3 |
| ERIC A. GULVE | 1 | 2 |
| Peter S. Finley | 1 | 2 |
| Daniel J. Broderick | 1 | 2 |
| James C. Wachtman | 1 | 2 |
| Rogers M. Ritter | 1 | 1 |
| Rogers A. Ritter | 1 | 1 |
| PEGGY STOHR | 1 | 1 |
| Francis M. Creighton | 1 | 1 |
| Stephen A. Wexler | 1 | 1 |
| Peggy A. Stohr | 1 | 1 |
| Sean A. Morris | 1 | 1 |
| Thomas J. Hillman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.